Dynavax Technologies | 应收帐款人



Trade Debtors 更改 日
AbbVie USD 10.92B 553M 2024-12
Adma Biologics USD 50M 141K 2024-12
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Dynavax Technologies USD 56.56M 9.65M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Merck USD 11.57B 452M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.74B 32M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
TG Therapeutics USD 129.18M 13.46M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Dynavax Technologies 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.